This company has been acquired
Coeptis Therapeutics Balance Sheet Health
Financial Health criteria checks 1/6
Key information
185.0%
Debt to equity ratio
US$3.81m
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.38m |
| Equity | US$2.06m |
| Total liabilities | US$4.46m |
| Total assets | US$6.52m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: COEP's short term assets ($2.4M) do not cover its short term liabilities ($4.3M).
Long Term Liabilities: COEP's short term assets ($2.4M) exceed its long term liabilities ($206.4K).
Debt to Equity History and Analysis
Debt Level: COEP's net debt to equity ratio (69.6%) is considered high.
Reducing Debt: Insufficient data to determine if COEP's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COEP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: COEP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 43.5% each year